342 related articles for article (PubMed ID: 19563503)
1. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.
Petta S; Cammà C; DI Marco V; Calvaruso V; Enea M; Bronte F; Butera G; Cabibi D; Craxì A
Aliment Pharmacol Ther; 2009 Sep; 30(6):603-13. PubMed ID: 19563503
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
3. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index.
Petta S; Di Marco V; Cammà C; Butera G; Cabibi D; Craxì A
Aliment Pharmacol Ther; 2011 Jun; 33(12):1350-60. PubMed ID: 21517924
[TBL] [Abstract][Full Text] [Related]
4. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
6. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
7. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
Tsochatzis E; Manolakopoulos S; Papatheodoridis GV; Hadziyannis E; Triantos C; Zisimopoulos K; Goulis I; Tzourmakliotis D; Akriviadis E; Manesis EK; Archimandritis AJ
Aliment Pharmacol Ther; 2009 Nov; 30(9):947-54. PubMed ID: 19604179
[TBL] [Abstract][Full Text] [Related]
8. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.
Lupşor M; Badea R; Stefănescu H; Grigorescu M; Sparchez Z; Serban A; Branda H; Iancu S; Maniu A
J Gastrointestin Liver Dis; 2008 Jun; 17(2):155-63. PubMed ID: 18568136
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.
Verveer C; Zondervan PE; ten Kate FJ; Hansen BE; Janssen HL; de Knegt RJ
Liver Int; 2012 Apr; 32(4):622-8. PubMed ID: 22098684
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy.
Calvaruso V; Cammà C; Di Marco V; Maimone S; Bronte F; Enea M; Dardanoni V; Manousou P; Pleguezuelo M; Xirouchakis E; Attanasio M; Dusheiko G; Burroughs AK; Craxì A
J Viral Hepat; 2010 Jul; 17(7):469-74. PubMed ID: 19780940
[TBL] [Abstract][Full Text] [Related]
12. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
Chan HL; Wong GL; Choi PC; Chan AW; Chim AM; Yiu KK; Chan FK; Sung JJ; Wong VW
J Viral Hepat; 2009 Jan; 16(1):36-44. PubMed ID: 18673426
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.
Marcellin P; Ziol M; Bedossa P; Douvin C; Poupon R; de Lédinghen V; Beaugrand M
Liver Int; 2009 Feb; 29(2):242-7. PubMed ID: 18637064
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
Ziol M; Handra-Luca A; Kettaneh A; Christidis C; Mal F; Kazemi F; de Lédinghen V; Marcellin P; Dhumeaux D; Trinchet JC; Beaugrand M
Hepatology; 2005 Jan; 41(1):48-54. PubMed ID: 15690481
[TBL] [Abstract][Full Text] [Related]
16. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
[TBL] [Abstract][Full Text] [Related]
17. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of transient elastography for the detection of hepatic fibrosis.
Stebbing J; Farouk L; Panos G; Anderson M; Jiao LR; Mandalia S; Bower M; Gazzard B; Nelson M
J Clin Gastroenterol; 2010 Mar; 44(3):214-9. PubMed ID: 19745758
[TBL] [Abstract][Full Text] [Related]
19. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
[TBL] [Abstract][Full Text] [Related]
20. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
